Sponsored symposia / workshops 

Friday 6 October 2017

Sponsored Diagnostic Symposium 1 (Bruker & OLM)
Molecular diagnostics PCR and beyond
Chair: Katrien Lagrou, Belgium

15.10   Aspergillus PCRP.
Lewis White, UK
15.25 Pneumocystis PCR
Alexandre Alanio, France
15.40 Mucoromycotina
Laurence Millon, France
15.55 Candida
Rebecca Gorton, UK
16.25 Discussion

Sponsored Integrated Symposium 1 (Merck Sharp & Dohme)

Chair: Livio Pagano

17.00        Welcome and Introduction
Livio Pagano
17.05 Invasive Fungal Infection RiskPrediction: Who of My Patients and When to Expect?
Christian Van Delden
17.25 Emerging Fungal Resistance Development:How Does It Develop and How to Deal With?
Paul Verweij
17.45 The Role of Antifungal Prophylaxis in Acute MyeloidLeukemia: From Diagnosis to Allogeneic HSCT
Livio Pagano
18.05 Real-Life Clinical Evidence of Posaconazole Tab and IV Use
Monica Slavin
18.25 Closing Remarks
Livio Pagano


Saturday 7 October 2017

Sponsored Diagnostic Workshop (Associates of Cape Cod)
1-3)-β-Glucan in the management of invasive fungal disease?
Chair: Martin Hoenigl, USA

08.00     Beta-glucan utility in suspected invasive fungal disease:Role of negative predictive value.
Maurizio Sanguinetti, Italy
08.30 Title to be confirmed
Thomas J. Walsh, USA

Sponsored Integrated Symposium 2 (Pfizer)
From Diagnosis to early Treatment in Invasive Fungal Disease (IFD)

Chairman: Matteo Bassetti

12.30       Welcome and introduction
Matteo Bassetti, Italy
12.40 Up-to-date diagnostics in invasive aspergillosis andmucormycosis
Dieter Buchheidt. Medizinische Klinik.
Universitätsmedizin Mannheim, Germany
13.00 Treatment options and benefits from early treatment vs.prophylaxis
Johan Maertens. Department of Hematology
Leukemia Stem Cell Transplantation Unit
University Hospitals Leuven, Belgium
13.20 Patients with invasive fungal infections
Matteo Bassetti, Italy
13.50 Discussion
Matteo Bassetti, Italy
14.00 Close

Sponsored Integrated Symposium 3 (Gilead)
This house believes that you can diagnose invasive aspergillosis in the intensive care unit
Chair: Johan Maertens, Belgium

The CARE debate
18.00         Introduction by chair
Johan Maertens, Belgium
18.15       Proposer: Diagnostic techniques are applicable to patientswith invasive aspergillosis in the intensive care unit
Paul Verweij, The Netherlands
18.30 Opposer: Diagnostic challenges in critically ill patientsmake early diagnosis of invasive aspergillosis too difficult
Russell Lewis, Italy
18.45 Audience Q&A
Moderated by Professor Johan Maertens, Belgium
18.55 Proposing seconder
Lewis White, UK
19.05 Opposing seconder
George Dimopoulos, Greece
19.15 Panel discussion
Moderated by Johan Maertens, Belgium
19.25 Summary and close
Johan Maertens, Belgium

Sunday 8 October 2017

Sponsored Integrated Symposium 4 (Pfizer)
Do we know everything we should about the management of invasive candidiasis?

Chair: Bart Jan Kullberg, The Netherlands

12.30        Welcome and introduction
Bart Jan Kullberg, The Netherlands
12.35 Let’s talk about the complexity of patients with invasivecandidiasis
Matteo Bassetti, Infectious Disease Specialist, Santa Maria
Misericordia University Hospital, Udine, Italy
13.00 Challenges in the treatment of invasive candidiasis insolid organ transplant patients
Georg Auzinger, Consultant Intensivist, King’s College
Hospital NHS Foundation Trust, London, UK
13.25 Current evidence for the treatment of invasivecandidiasis
Bart Jan Kullberg, The Netherlands
13.50 Q&A from the audience
14.00 Conclusions
Bart Jan Kullberg, The Netherlands